Venus Concept to Release Third Quarter of Fiscal Year 2024 Financial Results on November 13, 2024
Venus Concept Inc. (NASDAQ: VERO), a global medical aesthetic technology leader, has announced the release date for its third quarter fiscal year 2024 financial results. The results will be unveiled before the market opens on Wednesday, November 13, 2024. Following the release, management will host a conference call at 8:00 a.m. Eastern Time to discuss the quarterly results and conduct a question and answer session.
Interested participants can dial 877-407-2991 (201-389-0925 for international callers) and use the access code 13749236. A live webcast of the call will be available on the company's investor relations website. For those unable to attend, a two-week replay will be accessible via phone, and the webcast will be archived on the company's website.
Venus Concept Inc. (NASDAQ: VERO), un leader globale nella tecnologia estetica medica, ha annunciato la data di rilascio dei risultati finanziari del terzo trimestre dell'anno fiscale 2024. I risultati saranno svelati prima dell'apertura del mercato mercoledì 13 novembre 2024. A seguito del rilascio, il management ospiterà una teleconferenza alle 8:00 ora orientale per discutere i risultati trimestrali e condurre una sessione di domande e risposte.
I partecipanti interessati possono chiamare il 877-407-2991 (201-389-0925 per le chiamate internazionali) e utilizzare il codice di accesso 13749236. Una diretta webcast della chiamata sarà disponibile sul sito web delle relazioni con gli investitori della società. Per coloro che non possono partecipare, una replica di due settimane sarà accessibile tramite telefono, e la webcast sarà archiviata sul sito web della società.
Venus Concept Inc. (NASDAQ: VERO), un líder global en tecnología estética médica, ha anunciado la fecha de lanzamiento de sus resultados financieros del tercer trimestre del año fiscal 2024. Los resultados se darán a conocer antes de la apertura del mercado el miércoles 13 de noviembre de 2024. Tras el anuncio, la dirección llevará a cabo una conferencia telefónica a las 8:00 a.m. hora del Este para discutir los resultados trimestrales y realizar una sesión de preguntas y respuestas.
Los participantes interesados pueden marcar el 877-407-2991 (201-389-0925 para llamadas internacionales) y usar el código de acceso 13749236. Una transmisión en vivo de la llamada estará disponible en el sitio web de relaciones con inversores de la empresa. Para aquellos que no puedan asistir, habrá una repetición de dos semanas accesible por teléfono, y la transmisión estará archivada en la página web de la empresa.
Venus Concept Inc. (NASDAQ: VERO)는 세계적인 의료 미용 기술 리더로서 2024 회계연도 3분기 재무 결과의 발표 날짜를 발표했습니다. 결과는 2024년 11월 13일 수요일 시장 개장 전에 공개될 예정입니다. 발표 후, 경영진은 동부 표준시 오전 8시에 전화 회의를 개최하여 분기별 결과를 논의하고 질의응답 세션을 진행할 것입니다.
관심 있는 참가자는 877-407-2991 (해외 통화자는 201-389-0925)로 전화하여 접근 코드를 13749236를 사용할 수 있습니다. 회의의 생중계는 회사의 투자자 관계 웹사이트에서 이용할 수 있습니다. 참석할 수 없는 분들을 위해 2주간 재생이 전화로 접속 가능하며, 웹캐스트는 회사 웹사이트에 아카이빙될 것입니다.
Venus Concept Inc. (NASDAQ: VERO), un leader mondial dans la technologie esthétique médicale, a annoncé la date de publication de ses résultats financiers du troisième trimestre de l’exercice fiscal 2024. Les résultats seront dévoilés avant l'ouverture du marché le mercredi 13 novembre 2024. Suite à la publication, la direction animera une conférence téléphonique à 8h00, heure de l'Est pour discuter des résultats trimestriels et organiser une session de questions-réponses.
Les participants intéressés peuvent composer le 877-407-2991 (201-389-0925 pour les appelants internationaux) et utiliser le code d’accès 13749236. Un webinaire en direct de l'appel sera disponible sur le site web des relations avec les investisseurs de l'entreprise. Pour ceux qui ne peuvent pas assister, une rediffusion de deux semaines sera accessible par téléphone, et le webinaire sera archivé sur le site de l'entreprise.
Venus Concept Inc. (NASDAQ: VERO), ein weltweit führendes Unternehmen im Bereich medizinischerästhetischer Technologien, hat das Veröffentlichungsdatum seiner Finanzergebnisse für das dritte Quartal des Geschäftsjahres 2024 bekannt gegeben. Die Ergebnisse werden vor Markteröffnung am Mittwoch, den 13. November 2024, vorgestellt. Im Anschluss an die Veröffentlichung wird das Management eine Telefonkonferenz um 8:00 Uhr Eastern Time abhalten, um die Quartalsergebnisse zu besprechen und eine Fragen-und-Antworten-Runde durchzuführen.
Interessierte Teilnehmer können die Nummer 877-407-2991 (für internationale Anrufer 201-389-0925) anrufen und den Zugangscode 13749236 verwenden. Ein Live-Webcast der Konferenz wird auf der Investor-Relations-Website des Unternehmens verfügbar sein. Für diejenigen, die nicht teilnehmen können, wird eine Zwei-Wochen-Wiederholung telefonisch zugänglich sein, und der Webcast wird auf der Unternehmenswebsite archiviert.
- None.
- None.
TORONTO, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that third quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday, November 13, 2024.
Management will host a conference call at 8:00 a.m. Eastern Time on November 13, 2024 to discuss the results of the quarter with a question and answer session. Those who would like to participate may dial 877-407-2991 (201-389-0925 for international callers) and provide access code 13749236. A live webcast of the call will also be provided on the investor relations section of the Company's website at ir.venusconcept.com.
For those unable to participate, a replay of the call will be available for two weeks at: 877-660-6853 (201-612-7415 for international callers); access code 13749236. The webcast will be archived at ir.venusconcept.com.
About Venus Concept
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 12 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus Versa, Venus Versa PRO, Venus Legacy, Venus Velocity, Venus Viva, Venus Glow, Venus Bliss, Venus Bliss MAX, Venus Epileve, Venus Viva MD and AI.ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, Masters Special Situations, and Madryn Asset Management, L.P.
FAQ
When will Venus Concept (VERO) release its Q3 2024 financial results?
What time is Venus Concept's (VERO) Q3 2024 earnings call scheduled for?
How can investors participate in Venus Concept's (VERO) Q3 2024 earnings call?
Will there be a replay available for Venus Concept's (VERO) Q3 2024 earnings call?
